Selpercatinib is a special kind of medicine that targets RET inhibitor. It’s used to treat certain lung cancers, thyroid cancers, and some other types of cancers that have RET-altered tumors. It works by stopping the RET kinase, which is like a key the cancer cells use to grow.
They offer this drug in two sizes: tiny 40 mg caps and bigger 80 mg ones. Doctors suggest adults take 160 mg of it, twice a day, whether they’re eating or not. You’ll find selpercatinib in bottles, usually with 60 caps per bottle.
This treatment is all about targeting that RET mutation cancer loves, which gets cancer cells in RET-altered tumors to act up.
